← Human Trials & Peer-Reviewed Studies

Investigation of glutathione concentrations in peritoneal fluid from women with and without endometriosis

Plain-language guide to PMID 12860343 (2003): controlled clinical trial study of Glutathione in 29 patients, endometriosis.

Key Facts

PMID
12860343
Journal
European journal of obstetrics, gynecology, and reproductive biology
Year
2003
Study type
Controlled Clinical Trial
Authors
Polak G et al. (5 authors)
DOI
10.1016/s0301-2115(03)00076-9

What This Study Did, in Plain Language

What Was Tested

Researchers studied Glutathione in the context of endometriosis in this controlled clinical trial publication.

To evaluate the concentration of glutathione in PF of women with endometriosis.

Who Took Part

The abstract describes 29 patients taking part.

By PubMed's age tags, the people studied were adults, women only.

Twenty-one patients with endometriosis (I or II rAFS stage, n=11; III or IV rAFS stage, n=10), and 29 patients with follicular or dermoid ovarian cysts (n=17 and n=12, respectively).

What Was Measured

Topics PubMed links to this paper include Ascitic Fluid, Biomarkers, Dermoid Cyst, Diagnosis, Differential, Endometriosis, Glutathione and Luteal Phase.

What This Means in Plain Language

This is a controlled clinical trial of Glutathione in 29 patients in people with endometriosis.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 3 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2003 (European journal of obstetrics, gynecology, and reproductive biology), a journal based in Ireland.

More context: the Glutathione compound page, Endometriosis research.

Our Notes on the Compound

Glutathione: The body's main antioxidant.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.